For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Domperidone - Gastro Oesophageal Reflux Disorder (GORD)
PAD Profile : Domperidone - Gastro Oesophageal Reflux Disorder (GORD) Important
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
- Nausea and vomiting
- Lactation stimulation
- Dyspepsia
- Gastroparesis
- Nausea and vomiting (Parkinson's disease)
- Gastric reflux in Neonates and Children
- Nausea and vomiting (pregnancy)
- Parkinson's Disease (apomorphine pre-treatment)
- Nausea and vomiting (chemotherapy induced)
Additional Documents
Committee Recommendations
The Area Prescribing Committee recommends the use of domperidone for the treatment of gastro-oesophageal reflux disease (GORD) in adults only when prescribed within a secondary care setting.
Domperidone will be considered RED on the traffic light system for this indication.
Prescribers should ensure that the patient understands the risks and consents to using domperidone off-label noting the MHRA alert (updated 2019) - https://www.gov.uk/drug-safety-update/domperidone-risks-of-cardiac-side-effects
Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication